In CML, persistent STAT3 phosphorylation mediated by BCR-ABL has been associated with cellular proliferation, the inhibition of apoptosis and chemotherapy resistance [5, 15–19]. Here, STAT3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.